Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kimberly Daniels

Showing results (31-40 of 35) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 35 results.
Menopause (New York, N.Y.)|July 14, 2023
Comparative safety of conjugated estrogens/bazedoxifene versus estrogen/progestin combination hormone therapy among women in the United States: a multidatabase cohort studySarah R Hoffman, Samuel Governor, Kimberly Daniels, et al.
BMJ Open|March 19, 2026
Postmarketing safety surveillance for GSK's AS01<sub>E</sub>-adjuvanted respiratory syncytial virus prefusion F protein-based vaccine in the USA: protocol for a non-interventional postauthorisation safety studySruthi Adimadhyam, Dominique Luyts, Driss Oraichi, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|February 9, 2026
Post-authorization safety study to assess the risk of diabetic ketoacidosis among type 2 diabetes mellitus patients treated with ertugliflozin compared to patients treated with other antihyperglycaemic agents in a Medicare and Medicaid populationAshish Rai, James Marshall, Sampada Nandyala, et al.
RMD Open|August 8, 2025
Effectiveness and safety of the recombinant zoster vaccine in adult patients with systemic lupus erythematosus: a claims-based retrospective cohort study in the USASophie E Mayer, Sheryl A Kluberg, O'Mareen Spence, et al.
Seminars in Arthritis and Rheumatism|July 30, 2024
Risk of incident gout following exposure to recombinant zoster vaccine in US adults aged ≥50 yearsSheryl A Kluberg, Andrew L Simon, Sarah M Alam, et al.
Pageof 4

Showing results (31-40 of 35) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 35 results.
Menopause (New York, N.Y.)|July 14, 2023
Comparative safety of conjugated estrogens/bazedoxifene versus estrogen/progestin combination hormone therapy among women in the United States: a multidatabase cohort studySarah R Hoffman, Samuel Governor, Kimberly Daniels, et al.
BMJ Open|March 19, 2026
Postmarketing safety surveillance for GSK's AS01<sub>E</sub>-adjuvanted respiratory syncytial virus prefusion F protein-based vaccine in the USA: protocol for a non-interventional postauthorisation safety studySruthi Adimadhyam, Dominique Luyts, Driss Oraichi, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|February 9, 2026
Post-authorization safety study to assess the risk of diabetic ketoacidosis among type 2 diabetes mellitus patients treated with ertugliflozin compared to patients treated with other antihyperglycaemic agents in a Medicare and Medicaid populationAshish Rai, James Marshall, Sampada Nandyala, et al.
RMD Open|August 8, 2025
Effectiveness and safety of the recombinant zoster vaccine in adult patients with systemic lupus erythematosus: a claims-based retrospective cohort study in the USASophie E Mayer, Sheryl A Kluberg, O'Mareen Spence, et al.
Seminars in Arthritis and Rheumatism|July 30, 2024
Risk of incident gout following exposure to recombinant zoster vaccine in US adults aged ≥50 yearsSheryl A Kluberg, Andrew L Simon, Sarah M Alam, et al.
Pageof 4